Litcius/Paper detail

Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial

Christian T. Ruff, Michelle A. Baron, KyungAh Im, Michelle L. O’Donoghue, Fred T. Fiedorek, Marc S. Sabatine

2021Nature Medicine98 citationsDOI

Topics & Concepts

ExenatideMedicinePlaceboInternal medicineMyocardial infarctionAnginaHazard ratioAdverse effectRandomized controlled trialStroke (engine)Diabetes mellitusDulaglutideType 2 diabetesConfidence intervalSemaglutideUnstable anginaSurgeryLiraglutideEndocrinologyEngineeringMechanical engineeringPathologyAlternative medicineDiabetes Treatment and ManagementPharmaceutical studies and practicesStatistical Methods in Clinical Trials
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial | Litcius